OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Virology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Editorial Board	103
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	95
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	76
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	73
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	65
Inhaled aerosol viral-vectored vaccines against tuberculosis	64
Transmission patterns of hepatitis E virus	58
The enigmatic roles of Anelloviridae and Redondoviridae in humans	52
Editorial Board	50
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	49
Editorial overview: Viral pathogenesis	45
Human placental models for studying viral infections	43
Virus–host protein interactions as footprints of human cytomegalovirus replication	43
Intercellular highways of viral spread: tunneling nanotubes and extracellular vesicles at the maternal–fetal interface	39
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation	38
Editorial Board	36
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity	34
Recent progress in development of monoclonal antibodies against human cytomegalovirus	33
Shopping for phages? Unpacking design rules for therapeutic phage cocktails	31
Emerging technologies in the study of the virome	31
Platelets in the pathogenesis of flavivirus disease	30
Epigenetic control of the Epstein-Barr lifecycle	30
Mitigation of evolved bacterial resistance to phage therapy	30
A review of broadly protective monoclonal antibodies to treat Ebola virus disease	30
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	29

A complex immune communication between eicosanoids and pulmonary macrophages	29
Engineering therapeutic phages for enhanced antibacterial efficacy	29
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	28
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	27
Retasking of canonical antiviral factors into proviral effectors	27
Human organoid models to study coronavirus infections of the respiratory tract	26
Asymmetry in icosahedral viruses	25
When good turns bad: how viruses exploit innate immunity factors	25
Editorial Board	25
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	23
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	23
Tissue-resident memory T cells in protective immunity to influenza virus	22
Oncogenic Animal Herpesviruses	22
State-of-the-art in oncolytic virotherapy using adenoviruses other than the commonly applied adenovirus type 5	21
Modeling zoonotic and vector-borne viruses	21
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	19
Immune responses to human respiratory coronaviruses infection in mouse models	19
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	18
Severe fever with thrombocytopenia syndrome virus NSs: a multifaceted viral protein in host–virus interactions	17
Nexus of virus and brain: recent advances in flavivirus and enterovirus neuro-infection	17
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	17
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	17